Medifast: Significant Undervaluation Even As Struggles Persist (NYSE:MED)


Young woman taking a break from exercising outdoors

Tony Anderson/DigitalVision via Getty Images

Investment thesis

As I suggested in my initial cautious thesis about Medifast (NYSE:MED), the company faced tough times over the last seven months. The emergence of drug-weight loss weighs on Medifast’s business, and its

Leave a Reply

Your email address will not be published. Required fields are marked *